Return Peptide Library

Avexitide

CLevel 1 evidence

Avexitide

GLP-1 and incretin receptor agonists

AI Interpretation of This Peptide Generate Report

Basic Information

Categories

GLP-1 receptor antagonist

Overview

Exendin-4 C-terminal fragment-derived GLP-1 receptor antagonist, investigated for post-bariatric hypoglycemia and congenital hyperinsulinism.

Efficacy Rating

Research, GLP-1 antagonists, hypoglycemia

Evidence Level

Class C

Evidence Type

No data available

Confidence

No data available

China Regulatory Status

Cosmetic Ingredient Directory

No data available

Food/Supplements

No data available

Medicine

No data available

Similar Peptide Recommendations

ASC30

ASC30

CGLP-1 and incretin receptor agonists

Research, GLP-1, small molecules

Berobenatide

Berobenatide

CGLP-1 and incretin receptor agonists

GLP-1, Weight Loss, Obesity

DA-1726

DA-1726

CGLP-1 and incretin receptor agonists

Research, Weight Loss, GLP-1

Imapextide

Imapextide

CGLP-1 and incretin receptor agonists

Research: GLP-1 Antagonists and Post-Bariatric Hypoglycemia

Disclaimer

The content on this platform is for educational and informational purposes only and does not constitute medical advice, formulation guidance, or a guarantee of regulatory compliance. All efficacy claims are labeled with their evidence level; please consult a professional before making any decisions.